Success Metrics

Clinical Success Rate

90.0%

Based on 9 completed trials

Completion Rate

90%(9/10)

Active Trials

3(20%)

Results Posted

33%(3 trials)

Terminated

1(7%)

Phase Distribution

Ph not_applicable

13%

Ph phase_2

27%

Ph phase_1

47%

Ph early_phase_1

Ph phase_3

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution15 total trials

Early Phase 1First-in-human

1(6.7%)

Phase 1Safety & dosage

7(46.7%)

Phase 2Efficacy & side effects

4(26.7%)

Phase 3Large-scale testing

1(6.7%)

N/ANon-phased studies

2(13.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

90.0%

9 of 10 finished

Non-Completion Rate

10.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(4)

Completed(9)

Terminated(1)

Other(1)

Detailed Status

Completed9

Recruiting3

Not yet recruiting1

unknown1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

90.0%

Most Advanced

Phase 3

Trials by Phase

Early Phase 11 (6.7%)

Phase 17 (46.7%)

Phase 24 (26.7%)

Phase 31 (6.7%)

N/A2 (13.3%)

Trials by Status

not_yet_recruiting17%

unknown17%

terminated17%

recruiting320%

completed960%

Recent Activity

3 active trials

Showing 5 of 15

recruitingearly_phase_1

Understanding How Opioids Affect the Experiential and Neural Signatures of Social Experiences

NCT05007561

not_yet_recruitingphase_1

A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients

NCT07398404

recruitingphase_1

Development of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients

NCT07224087

completedphase_2

Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis

NCT03482479

completedphase_2

Intermittent Oral Naltrexone Enhanced With an Ecological Momentary Intervention for Methamphetamine-using MSM

NCT04791969

View all 15 trials

Clinical Trials (15)

Showing 15 of 15 trials

NCT05007561Early Phase 1

Understanding How Opioids Affect the Experiential and Neural Signatures of Social Experiences

Recruiting

NCT07398404Phase 1

A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients

Not Yet Recruiting

NCT07224087Phase 1

Development of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients

Recruiting

NCT03482479Phase 2

Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis

Completed

NCT04791969Phase 2

Intermittent Oral Naltrexone Enhanced With an Ecological Momentary Intervention for Methamphetamine-using MSM

Completed

NCT05073679Phase 2

Oral Naltrexone In Pediatric Eating Disorders

Terminated

NCT02454712Phase 1

Study of PF614 Compared to OxyContin® in Healthy Volunteers (PF614-101)

Completed

NCT05090280Phase 1

Pharmacokinetics of Oxycodone and PF614 Co-Administered with Nafamostat (PF614-MPAR-101)

Completed

NCT05043766Phase 1

Evaluation of Oral PF614 Relative to OxyContin (PF614-102)

Completed

NCT05955313Phase 2

Effectiveness of Low-dose Naltrexone in Patients With Different Types of Vulvodynia

Recruiting

NCT05924893Not Applicable

The Use of Naltrexone Hydrochloride to Promote Healing in Patients With Resistant Non-infectious Corneal Ulcer

Completed

NCT03879460Phase 1

The Evaluation of Safety and Tolerance of Commercially Available Naltrexone Administered Daily - Assessment for CBRN Operations

Completed

NCT00302133Phase 1

Optimizing Pharmacotherapy for Bipolar Alcoholics

Completed

NCT00018213Not Applicable

Naltrexone and Patch for Smokers

Completed

NCT00065936Phase 3

Self-Injury: Diagnosis and Treatment

Unknown

All 15 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 15